News & Discoveries

August 15, 2019

In a paper researchers describe a technique that uses a special version of CRISPR developed at UCSF to systematically alter the activity of genes in human neurons generated from stem cells, the first successful merger of stem cell-derived cell types and CRISPR screening technologies.

August 12, 2019

Study Suggests Tau Tangles, Not Amyloid Plaques, Drive Daytime Napping That Precedes DementiaUCSF scientists show that Alzheimer’s disease directly attacks brain regions responsible for wakefulness during the day.

July 30, 2019

Study Is Step Toward One Day Treating People with Speech LossUCSF scientists have for the first time decoded spoken words and phrases in real time from the brain signals that control speech.

July 30, 2019

Since 2017, UCSF researchers Winston Chiong and Eddie Chang have led a collaborative neuroethics research project funded by the NIH.

July 29, 2019

Places Among Nation’s Most Renowned for Excellence in 15 Adult SpecialtiesFor the 21st year, UCSF Health has been listed among the top 10 hospitals nationwide in the prestigious U.S. News & World Report’s Best Hospitals survey.

July 17, 2019

Discovery Could Inform Future MS Immunotherapies Brain damage associated with MS specifically targets a common class of brain cells called projection neurons

July 11, 2019

With New Commitment, Couple’s Total Giving to ‘UCSF: The Campaign’ Reaches $50MThe Susan and Bill Oberndorf Foundation has made a new commitment of $25 million to UCSF psychiatry and the neurosciences, bringing its total giving to "UCSF: The Campaign" to $50 million.

July 05, 2019

Technology that Uncovered Antibody Has Potential to Identify Other Autoimmune DiseasesUsing advanced technology, scientists have discovered an autoimmune disease that appears to affect men with testicular cancer.

July 01, 2019

The commitment reflects the ambitions of Atlantic Philanthropies and its founder, Charles “Chuck” Feeney, to advance fairer, healthier and more inclusive societies.

June 21, 2019

New finding in mice highlights potential postnatal therapeutic target for the disorderUnlike other gene mutations linked to autism, which are thought to alter brain development before birth, the newly identified changes in brain signaling may occur closer to the onset of autism symptoms in the first years of life.